According to reports, the UK will provide one-third of the Pfizer “Booster jab” before winter as Research Shows that it will provide people with better protection to prevent Delta variants.
The plan is Will start in September. It seems that there are approximately 23 million people over 50 years old, classified as disadvantaged and NHS Worker And the nursing staff provided a third Pfizer injection, even if they had other options vaccine forward.
Initially, it was thought that the person who received the third injection would receive the same vaccine as the original one-but now it is thought that everyone will receive Pfizer. This is because scientists have found that this is the most effective way to combat Delta variants.
A source told the New York Times that those vaccinated with AstraZeneca will “get an “mRNA booster”-which means Pfizer or Moderna vaccine.
The Pfizer and Moderna vaccines are mRNA vaccines because they tell the body’s cells to produce proteins from the virus, thereby causing the body to produce an immune response. This means that those who have received the mRNA jab can be protected from the virus.
Oxford AstraZeneca is not an mRNA vaccine.
The government stated that analysis showed that the Pfizer vaccine is 96% effective against the Delta variant.
Studies have shown that the effective rate of the Oxford/AstraZeneca vaccine for hospitalization after two doses is 92%.
At the same time, another government-backed study published earlier this year found that mixed vaccines may bring higher protection.
According to reports, the vaccine will be launched in two stages, prioritizing the vaccine with the highest risk before being promoted to others.
